Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20190105042236N1Phase 3Completed
Phase 3, randomised trial of magnesium sulfate in Cardiovascular Instability (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Perioperative cardiovascular parameter changes. Started Oct 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20190105042236N1.